PennyStocksUpdate.biz is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
New York, NY -- (SBWIRE) -- 02/27/2013 -- Shares of Accretive Health Inc (NYSE:AH) fell more than 30 percent before the bell, as the medical billing service provider withdrew its forecast and indefinitely delayed the filing of its fourth-quarter results, saying it was evaluating the timing of revenue recognition.
Accretive Health, which was scheduled to report fourth-quarter results on Wednesday, disclosed that it ended 2012 with no debt and about $177 million in cash and cash equivalents.Analysts on average expect the Chicago-based company to report earnings of about 9 cents per share on revenue of $237.2 million, according to Thomson Reuters I/B/E/S.Accretive Health's stock, which has lost more than half its value over the past year, was trading at $8.35 before the bell. They closed at $12.11 on Tuesday on the New York Stock Exchange.
How Should Investors React To AH Now? Check here
First Solar Inc. (NASDAQ:FSLR) reported fourth quarter non-GAAP EPS of $2.04 after the bell Tuesday, which topped the consensus estimate of $1.76. First quarter EPS is expected to be between $0.70 and $0.90. The consensus estimate is for EPS of $0.94.First Solar has gapped open sharply lower Wednesday morning and is now down 4.42 at $26.94. The stock has dropped to a 3-month low.
Click here to receive FREE breaking news email alerts for First Solar Inc.
Cincinnati Bell (NYSE:CBB) announced its earnings results on Wednesday. The company reported ($0.06) EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.05 by $0.11. The company had revenue of $375.00 million for the quarter, compared to the consensus estimate of $367.72 million. Cincinnati Bell (CBB) opened at 4.15 on Wednesday. Cincinnati Bell (CBB) has a 1-year low of $3.33 and a 1-year high of $5.89. The stock’s 50-day moving average is currently $4.79. The company’s market cap is $827.6 million.
How Should Investors Trade CBB Now? Find Out Here
Papa John’s (NASDAQ:PZZA) declared net income of $61.7M, or $2.58 a share for the year, diluted, increased from $54.7M, or $2.16 a share, a year before. Revenue for the year surged to $1.34B from $1.22B.
Shares of Papa John’s Int’l, Inc. (NASDAQ:PZZA) traded at $56.65 by increasing +1.14% with price volatility of 1.88% for a week and 1.97% for a month plus price volatility’s Average True Range for 14 days was 1.07 and its beta stands at 0.60 times.
Stocks after opening at $56.05 hit a high price of $57.32 and on last session stock held volume of 294,353 shares which was unexpectedly higher than its average volume of 91,646 shares.
Are these stocks a buy or sell? Let us help you decide, Check here
DISCLAIMER
Neither PennyStocksUpdate.biz nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by PennyStocksUpdate.biz, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.PennyStocksUpdate.biz makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through PennyStocksUpdate.biz. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in..
Contact:
PennyStocksUpdate.biz
info@pennystocksupdate.biz
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)